{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:33:35Z","timestamp":1793716415781,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003803","name":"The University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ymthe.2024.10.025","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T05:38:37Z","timestamp":1730093917000},"page":"4435-4447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["N6-Methyladenosine modification activates the serine synthesis pathway to mediate therapeutic resistance in liver cancer"],"prefix":"10.1016","volume":"32","author":[{"given":"For-Fan","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth Kin-Leung","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Hyun","family":"Seoung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don Wai-Ching","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Oi-Lin","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Chak-Lui","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ming","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.10.025_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.ymthe.2024.10.025_bib2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2024.10.025_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2024.10.025_bib4","article-title":"RNA m(6)A Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications","volume":"1","author":"Gu","year":"2020","journal-title":"Innovation."},{"key":"10.1016\/j.ymthe.2024.10.025_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12943-020-01172-y","article-title":"The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis","volume":"19","author":"Chen","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2024.10.025_bib6","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/hep.29683","article-title":"RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2","volume":"67","author":"Chen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2024.10.025_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/hep.28885","article-title":"METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing","volume":"65","author":"Ma","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2024.10.025_bib8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.10.025_bib9","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2024.10.025_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2024.10.025_bib11","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","article-title":"The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia","volume":"40","author":"Weng","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2024.10.025_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115940","article-title":"Development of a specific and potent IGF2BP1 inhibitor: A promising therapeutic agent for IGF2BP1-expressing cancers","volume":"263","author":"Singh","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ymthe.2024.10.025_bib13","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/s41375-022-01651-9","article-title":"Inhibition of the m(6)A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia","volume":"36","author":"Feng","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2024.10.025_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/10715761003667554","article-title":"Reactive oxygen species in cancer","volume":"44","author":"Liou","year":"2010","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ymthe.2024.10.025_bib15","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-021-03796-6","article-title":"Cycling cancer persister cells arise from lineages with distinct programs","volume":"596","author":"Oren","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.10.025_bib16","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc.2016.81","article-title":"Serine and one-carbon metabolism in cancer","volume":"16","author":"Yang","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2024.10.025_bib17","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1038\/s41467-019-12606-7","article-title":"Genome-wide CRISPR\/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC","volume":"10","author":"Wei","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.10.025_bib18","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.molcel.2014.05.015","article-title":"Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance","volume":"54","author":"Easwaran","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2024.10.025_bib19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jhep.2022.10.037","article-title":"Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses","volume":"78","author":"Yuen","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2024.10.025_bib20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41587-022-01487-9","article-title":"Absolute quantification of single-base m(6)A methylation in the mammalian transcriptome using GLORI","volume":"41","author":"Liu","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.10.025_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.10.025_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216122","article-title":"METTL3-m(6)A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma","volume":"559","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2024.10.025_bib23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s42255-023-00808-9","article-title":"m(6)A modification-tuned sphingolipid metabolism regulates postnatal liver development in male mice","volume":"5","author":"Wang","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ymthe.2024.10.025_bib24","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s42255-022-00622-9","article-title":"N(6)-methyladenosine (m(6)A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation","volume":"4","author":"Peng","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ymthe.2024.10.025_bib25","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.gastro.2023.01.041","article-title":"N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT\/beta-Catenin and Hippo Signaling Pathways","volume":"164","author":"Wang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymthe.2024.10.025_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s43018-021-00315-4","article-title":"The cancer-testis lncRNA lnc-CTHCC promotes hepatocellular carcinogenesis by binding hnRNP K and activating YAP1 transcription","volume":"3","author":"Xia","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ymthe.2024.10.025_bib27","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jhep.2023.06.021","article-title":"Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis","volume":"79","author":"Wang","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2024.10.025_bib28","article-title":"METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy","volume":"4","author":"Pan","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ymthe.2024.10.025_bib29","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1007\/s00018-012-1186-z","article-title":"Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?","volume":"70","author":"Bell","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2024.10.025_bib30","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.22459","article-title":"RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma","volume":"48","author":"Jeng","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2024.10.025_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tibs.2014.02.004","article-title":"Serine and glycine metabolism in cancer","volume":"39","author":"Amelio","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ymthe.2024.10.025_bib32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10350","article-title":"Functional genomics reveal that the serine synthesis pathway is essential in breast cancer","volume":"476","author":"Possemato","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.10.025_bib33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41586-022-04758-2","article-title":"PHGDH heterogeneity potentiates cancer cell dissemination and metastasis","volume":"605","author":"Rossi","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.10.025_bib34","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1158\/2159-8290.CD-19-1228","article-title":"Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition","volume":"10","author":"Ngo","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2024.10.025_bib35","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ng.890","article-title":"Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis","volume":"43","author":"Locasale","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.10.025_bib36","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41467-023-36708-5","article-title":"PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.10.025_bib37","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/cr.2015.33","article-title":"cMyc-mediated activation of serine biosynthesis pathway is critical\u00a0for cancer progression under nutrient deprivation conditions","volume":"25","author":"Sun","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2024.10.025_bib38","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1172\/JCI90253","article-title":"Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma","volume":"127","author":"Lee","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.10.025_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109706","article-title":"ATF3 promotes the serine synthesis pathway and tumor growth under dietary serine restriction","volume":"36","author":"Li","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2024.10.025_bib40","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/ng.3421","article-title":"NRF2 regulates serine biosynthesis in non-small cell lung cancer","volume":"47","author":"DeNicola","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.10.025_bib41","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.celrep.2017.05.067","article-title":"PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis","volume":"19","author":"Zhang","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2024.10.025_bib42","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41586-021-03741-7","article-title":"EGFR activation limits the response of liver cancer to lenvatinib","volume":"595","author":"Jin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.10.025_bib43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2024.10.025_bib44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1053\/j.gastro.2020.03.074","article-title":"Hepatocellular Carcinoma Cells Upregulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice","volume":"159","author":"Chiu","year":"2020","journal-title":"Gastroenterology"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624006853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624006853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T03:18:32Z","timestamp":1764818312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624006853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1525001624006853"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.10.025","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N6-Methyladenosine modification activates the serine synthesis pathway to mediate therapeutic resistance in liver cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}